YungShin Global Holding Corporation (3705.TW)
TWD 63.3
(2.1%)
TWD 63.3
(2.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.02 Billion TWD | -3.88% |
| 2022 | 7.31 Billion TWD | -6.32% |
| 2021 | 7.8 Billion TWD | -3.46% |
| 2020 | 8.08 Billion TWD | -1.3% |
| 2019 | 8.19 Billion TWD | 9.02% |
| 2018 | 7.51 Billion TWD | 13.45% |
| 2017 | 6.62 Billion TWD | 6.97% |
| 2016 | 6.19 Billion TWD | 2.6% |
| 2015 | 6.03 Billion TWD | 3.56% |
| 2014 | 5.82 Billion TWD | 15.11% |
| 2013 | 5.06 Billion TWD | 7.63% |
| 2012 | 4.7 Billion TWD | 4.47% |
| 2011 | 4.5 Billion TWD | 8.66% |
| 2010 | 4.14 Billion TWD | 1.56% |
| 2009 | 4.07 Billion TWD | 333.7% |
| 2008 | 940.62 Million TWD | 0.0% |
| 2006 | 2.96 Billion TWD | 5.44% |
| 2005 | 2.8 Billion TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.97 Billion TWD | 9.95% |
| 2024 Q1 | 1.79 Billion TWD | -7.59% |
| 2023 Q4 | 1.94 Billion TWD | 13.02% |
| 2023 FY | 7.02 Billion TWD | -3.88% |
| 2023 Q1 | 1.67 Billion TWD | -5.95% |
| 2023 Q2 | 1.69 Billion TWD | 1.23% |
| 2023 Q3 | 1.72 Billion TWD | 1.69% |
| 2022 Q3 | 1.62 Billion TWD | -16.9% |
| 2022 FY | 7.31 Billion TWD | -6.32% |
| 2022 Q1 | 1.95 Billion TWD | -6.14% |
| 2022 Q2 | 1.95 Billion TWD | 0.05% |
| 2022 Q4 | 1.77 Billion TWD | 9.35% |
| 2021 Q2 | 1.91 Billion TWD | 7.88% |
| 2021 Q3 | 2.02 Billion TWD | 5.51% |
| 2021 FY | 7.8 Billion TWD | -3.46% |
| 2021 Q4 | 2.08 Billion TWD | 2.84% |
| 2021 Q1 | 1.77 Billion TWD | -19.69% |
| 2020 Q2 | 1.94 Billion TWD | -2.22% |
| 2020 Q4 | 2.21 Billion TWD | 13.94% |
| 2020 Q3 | 1.94 Billion TWD | 0.16% |
| 2020 Q1 | 1.98 Billion TWD | -12.81% |
| 2020 FY | 8.08 Billion TWD | -1.3% |
| 2019 Q2 | 2.06 Billion TWD | 15.14% |
| 2019 Q4 | 2.27 Billion TWD | 10.66% |
| 2019 FY | 8.19 Billion TWD | 9.02% |
| 2019 Q1 | 1.79 Billion TWD | -14.47% |
| 2019 Q3 | 2.05 Billion TWD | -0.36% |
| 2018 Q2 | 1.79 Billion TWD | 2.81% |
| 2018 FY | 7.51 Billion TWD | 13.45% |
| 2018 Q3 | 1.87 Billion TWD | 4.17% |
| 2018 Q1 | 1.74 Billion TWD | -3.18% |
| 2018 Q4 | 2.09 Billion TWD | 11.98% |
| 2017 Q1 | 1.54 Billion TWD | -3.35% |
| 2017 Q2 | 1.55 Billion TWD | 0.78% |
| 2017 Q4 | 1.8 Billion TWD | 5.58% |
| 2017 FY | 6.62 Billion TWD | 6.97% |
| 2017 Q3 | 1.71 Billion TWD | 9.64% |
| 2016 Q1 | 1.44 Billion TWD | -9.06% |
| 2016 Q4 | 1.6 Billion TWD | 2.45% |
| 2016 Q3 | 1.56 Billion TWD | -1.45% |
| 2016 FY | 6.19 Billion TWD | 2.6% |
| 2016 Q2 | 1.58 Billion TWD | 10.07% |
| 2015 FY | 6.03 Billion TWD | 3.56% |
| 2015 Q1 | 1.44 Billion TWD | -5.7% |
| 2015 Q2 | 1.54 Billion TWD | 6.8% |
| 2015 Q3 | 1.46 Billion TWD | -5.02% |
| 2015 Q4 | 1.58 Billion TWD | 8.2% |
| 2014 Q3 | 1.45 Billion TWD | -3.27% |
| 2014 Q2 | 1.5 Billion TWD | 11.65% |
| 2014 FY | 5.82 Billion TWD | 15.11% |
| 2014 Q4 | 1.53 Billion TWD | 5.48% |
| 2014 Q1 | 1.34 Billion TWD | -4.71% |
| 2013 FY | 5.06 Billion TWD | 7.63% |
| 2013 Q1 | 1.13 Billion TWD | -5.7% |
| 2013 Q3 | 1.3 Billion TWD | 7.16% |
| 2013 Q2 | 1.21 Billion TWD | 6.62% |
| 2013 Q4 | 1.41 Billion TWD | 8.47% |
| 2012 Q2 | 1.23 Billion TWD | 5.83% |
| 2012 FY | 4.7 Billion TWD | 4.47% |
| 2012 Q1 | 1.16 Billion TWD | -2.54% |
| 2012 Q4 | 1.2 Billion TWD | 11.05% |
| 2012 Q3 | 1.08 Billion TWD | -12.17% |
| 2011 Q3 | 1.09 Billion TWD | 0.0% |
| 2011 Q2 | - TWD | -100.0% |
| 2011 Q1 | 1.07 Billion TWD | -74.16% |
| 2011 FY | 4.5 Billion TWD | 8.66% |
| 2011 Q4 | 1.19 Billion TWD | 9.64% |
| 2010 Q2 | - TWD | 0.0% |
| 2010 FY | 4.14 Billion TWD | 1.56% |
| 2010 Q4 | 4.14 Billion TWD | 0.0% |
| 2010 Q1 | - TWD | 0.0% |
| 2010 Q3 | - TWD | 0.0% |
| 2009 FY | 4.07 Billion TWD | 333.7% |
| 2008 FY | 940.62 Million TWD | 0.0% |
| 2006 FY | 2.96 Billion TWD | 5.44% |
| 2005 FY | 2.8 Billion TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Grape King Bio Ltd | 10.63 Billion TWD | 33.904% |
| Standard Chem & Pharm CO., LTD. | 6.23 Billion TWD | -12.631% |
| Maywufa Company Ltd. | 1.3 Billion TWD | -440.311% |
| ScinoPharm Taiwan, Ltd. | 3.18 Billion TWD | -120.582% |
| Lotus Pharmaceutical Co., Ltd. | 16.95 Billion TWD | 58.557% |
| LIWANLI Innovation Co., Ltd. | 38.88 Million TWD | -17972.716% |
| PhytoHealth Corporation | 162.48 Million TWD | -4225.177% |
| SCI Pharmtech, Inc. | 1.2 Billion TWD | -483.639% |
| Formosa Laboratories, Inc. | 4.36 Billion TWD | -61.175% |
| PharmaEssentia Corporation | 5.1 Billion TWD | -37.651% |
| Bora Pharmaceuticals Co., LTD. | 14.2 Billion TWD | 50.508% |